Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Pfizer director Ronald E Blaylock bought about $999K of company shares
Traded Aug 5, 2026 · Filed Aug 5, 2026
- ~$999K
- Reported value · 39K sh @ $25.46
- 67K
- Holds after · shares reported
- +8.9%
- stock since the trade · S&P 500 -0.8%, $25.81 → $28.12 on Oct 1
Why it stands out
A board member of Pfizer spent $999K of their very own money to buy Pfizer shares. 2 other people at Pfizer bought some too, in the same month. Their pile of Pfizer shares grew by 142%.
- Bought on the open market with their own money
- Raised their holdings by 142%
- 3 different insiders at Pfizer bought within a month
- No other insider purchase at Pfizer in the past year
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 5, 2026
Director$500K–$1MHoldings +142%3 insiders bought in 30d
Context
- Classification
open market purchase
Code P — open-market or private purchase
- Absolute commitment
~$998,821
Shares × reported transaction price
- Size band
$500K–$1M
